4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Calorie restriction slows age-related microbiota changes in an Alzheimer’s disease model in female mice

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Alzheimer’s disease (AD) affects an estimated 5.8 million Americans, and advanced age is the greatest risk factor. AD patients have altered intestinal microbiota. Accordingly, depleting intestinal microbiota in AD animal models reduces amyloid-beta (Aβ) plaque deposition. Age-related changes in the microbiota contribute to immunologic and physiologic decline. Translationally relevant dietary manipulations may be an effective approach to slow microbiota changes during aging. We previously showed that calorie restriction (CR) reduced brain Aβ deposition in the well-established Tg2576 mouse model of AD. Presently, we investigated whether CR alters the microbiome during aging. We found that female Tg2576 mice have more substantial age-related microbiome changes compared to wildtype (WT) mice, including an increase in Bacteroides, which were normalized by CR. Specific gut microbiota changes were linked to Aβ levels, with greater effects in females than in males. In the gut, Tg2576 female mice had an enhanced intestinal inflammatory transcriptional profile, which was reversed by CR. Furthermore, we demonstrate that Bacteroides colonization exacerbates Aβ deposition, which may be a mechanism whereby the gut impacts AD pathogenesis. These results suggest that long-term CR may alter the gut environment and prevent the expansion of microbes that contribute to age-related cognitive decline.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota

          Alzheimer’s disease is the most common form of dementia in the western world, however there is no cure available for this devastating neurodegenerative disorder. Despite clinical and experimental evidence implicating the intestinal microbiota in a number of brain disorders, its impact on Alzheimer’s disease is not known. To this end we sequenced bacterial 16S rRNA from fecal samples of Aβ precursor protein (APP) transgenic mouse model and found a remarkable shift in the gut microbiota as compared to non-transgenic wild-type mice. Subsequently we generated germ-free APP transgenic mice and found a drastic reduction of cerebral Aβ amyloid pathology when compared to control mice with intestinal microbiota. Importantly, colonization of germ-free APP transgenic mice with microbiota from conventionally-raised APP transgenic mice increased cerebral Aβ pathology, while colonization with microbiota from wild-type mice was less effective in increasing cerebral Aβ levels. Our results indicate a microbial involvement in the development of Abeta amyloid pathology, and suggest that microbiota may contribute to the development of neurodegenerative diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            2013 Alzheimer's disease facts and figures.

            (2013)
            This report provides information to increase understanding of the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality rates, health expenditures and costs of care, and effect on caregivers and society in general. It also explores the roles and unique challenges of long-distance caregivers, as well as interventions that target those challenges. An estimated 5.2 million Americans have AD. Approximately 200,000 people younger than 65 years with AD comprise the younger onset AD population; 5 million comprise the older onset AD population. Throughout the coming decades, the baby boom generation is projected to add about 10 million to the total number of people in the United States with AD. Today, someone in America develops AD every 68 seconds. By 2050, one new case of AD is expected to develop every 33 seconds, or nearly a million new cases per year, and the total estimated prevalence is expected to be 13.8 million. AD is the sixth leading cause of death in the United States and the fifth leading cause of death in Americans age 65 years or older. Between 2000 and 2010, the proportion of deaths resulting from heart disease, stroke, and prostate cancer decreased 16%, 23%, and 8%, respectively, whereas the proportion resulting from AD increased 68%. The number of deaths from AD as determined by official death certificates (83,494 in 2010) likely underrepresents the number of AD-related deaths in the United States. A projected 450,000 older Americans with AD will die in 2013, and a large proportion will die as a result of complications of AD. In 2012, more than 15 million family members and other unpaid caregivers provided an estimated 17.5 billion hours of care to people with AD and other dementias, a contribution valued at more than $216 billion. Medicare payments for services to beneficiaries age 65 years and older with AD and other dementias are three times as great as payments for beneficiaries without these conditions, and Medicaid payments are 19 times as great. Total payments in 2013 for health care, long-term care, and hospice services for people age 65 years and older with dementia are expected to be $203 billion (not including the contributions of unpaid caregivers). An estimated 2.3 million caregivers of people with AD and other dementias live at least 1 hour away from the care recipient. These "long-distance caregivers" face unique challenges, including difficulty in assessing the care recipient's true health condition and needs, high rates of family disagreement regarding caregiving decisions, and high out-of-pocket expenses for costs related to caregiving. Out-of-pocket costs for long-distance caregivers are almost twice as high as for local caregivers. Copyright © 2013. Published by Elsevier Inc.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Bacterial colonization factors control specificity and stability of the gut microbiota

              Mammals harbor a complex gut microbiome, comprised of bacteria that confer immunologic, metabolic and neurologic benefits 1 . Despite advances in sequence-based microbial profiling and myriad studies defining microbiome composition during health and disease, little is known about the molecular processes employed by symbiotic bacteria to stably colonize the gastrointestinal (GI) tract. We sought to define how mammals assemble and maintain the Bacteroides, one of the most numerically prominent genera of the human microbiome. While the gut normally contains hundreds of bacterial species 2,3 , we surprisingly find that germ-free mice mono-associated with a single Bacteroides are resistant to colonization by the same, but not different, species. To identify bacterial mechanisms for species-specific saturable colonization, we devised an in vivo genetic screen and discovered a unique class of Polysaccharide Utilization Loci (PUL) that are conserved among intestinal Bacteroides. We named this genetic locus the commensal colonization factors (ccf). Deletion of the ccf genes in the model symbiont, Bacteroides fragilis, results in colonization defects in mice and reduced horizontal transmission. The ccf genes of B. fragilis are up-regulated during gut colonization, preferentially at the colonic surface. When we visualize microbial biogeography within the colon, B. fragilis penetrates the colonic mucus and resides deep within crypt channels, while ccf mutants are defective in crypt association. Remarkably, the CCF system is required for B. fragilis colonization following microbiome disruption with Citrobacter rodentium infection or antibiotic treatment, suggesting the niche within colonic crypts represents a reservoir for bacteria to maintain long-term colonization. These findings reveal that intestinal Bacteroides have evolved species-specific physical interactions with the host that mediate stable and resilient gut colonization, and the CCF system represents a novel molecular mechanism for symbiosis.
                Bookmark

                Author and article information

                Contributors
                Lcox@bwh.harvard.edu
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                29 November 2019
                29 November 2019
                2019
                : 9
                : 17904
                Affiliations
                [1 ]Ann Romney Center for Neurologic Diseases, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA USA
                [2 ]ISNI 0000 0001 2109 4251, GRID grid.240324.3, Department of Medicine, , NYU Langone Medical Center, ; New York, NY USA
                [3 ]ISNI 0000 0001 2109 4251, GRID grid.240324.3, Cellular and Molecular Biology Training Program, , NYU Langone Medical Center, ; New York, NY USA
                [4 ]ISNI 0000 0001 2109 4251, GRID grid.240324.3, Psychiatry, Neuroscience & Physiology & the NYU Neuroscience Institute, , NYU Langone Medical Center, ; New York, NY USA
                [5 ]ISNI 0000 0001 2189 4777, GRID grid.250263.0, Center for Dementia Research, , Nathan Kline Institute, ; Orangeburg, NY USA
                [6 ]ISNI 0000 0004 0459 167X, GRID grid.66875.3a, Department of Physical Medicine and Rehabilitation and Robert and Arlene Kogod Center on Aging, , Mayo Clinic, ; Rochester, MN US
                [7 ]ISNI 0000 0004 1936 9887, GRID grid.273335.3, Jacobs School of Medicine and Biomedical Sciences, , University at Buffalo, State University of New York, ; Buffalo, NY USA
                [8 ]ISNI 0000000121839049, GRID grid.5333.6, Ecole Polytechnique Fédérale de Lausanne (EPFL), ; Lausanne, Switzerland
                [9 ]ISNI 0000 0004 1936 8796, GRID grid.430387.b, Center for Advanced Biotechnology and Medicine, , Rutgers University, ; New Brunswick, NJ USA
                Author information
                http://orcid.org/0000-0002-9564-9894
                http://orcid.org/0000-0001-6728-136X
                http://orcid.org/0000-0002-1797-4288
                http://orcid.org/0000-0003-2447-2443
                Article
                54187
                10.1038/s41598-019-54187-x
                6884494
                31784610
                2c076b3a-3cf1-4835-8be4-380a9874afef
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 21 May 2019
                : 9 November 2019
                Funding
                Funded by: FundRef https://doi.org/10.13039/100008552, BWH | Brigham Research Institute (BWH Brigham Research Institute);
                Funded by: FundRef https://doi.org/10.13039/100000093, U.S. Department of Health & Human Services | NIH | Center for Information Technology (Center for Information Technology, National Institutes of Health);
                Award ID: UL1-RR029893
                Award Recipient :
                Funded by: Women's Alzheimer's Movement Award Harvard NeuroDiscovery Pilot Award Women’s Brain Initiative Fellowship at Brigham & Women’s Hospital
                Funded by: C&D and Zlinkoff funds
                Categories
                Article
                Custom metadata
                © The Author(s) 2019

                Uncategorized
                alzheimer's disease,microbiome
                Uncategorized
                alzheimer's disease, microbiome

                Comments

                Comment on this article